Integra Lifesciences Holdings Corp at Piper Sandler Healthcare Conference Transcript
' -
All right. Good afternoon, everybody. Thanks so much for joining us. Matt O'Brien. I cover medical technology here at Piper Sandler. I'm very fortunate to have Integra with us here. From the company is Jan, who is the CEO, and then a couple of folks from IR are out in the audience. So thanks so much for coming out. I really do appreciate it.
Great to be here, Matt.
Questions & Answers
' -
Excellent. So maybe start a little bit with Q3. It was a little bit better than you expected, a little more stable than I think a lot of folks, I guess, generally, were expecting for Medtech. So what did you see in Q3? And then the early days of Q4 that, prior to the earnings call, what were you seeing
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
